Dr. Gopal R. Desai, MD

Dr. Desai practices at Rutgers Cancer Institute of New Jersey in Tinton Falls, New Jersey.

Dr. Desai's NPI, 1104870450, was assigned on May 20, 2006. Dr. Desai graduated from Kurnool Medical College in 1979. Dr. Desai's New Jersey license number on file is 25MA06695600.

Dr. Desai's primary practice is Rutgers Cancer Institute of New Jersey, at 66 Gilbert W St, Tinton Falls, NJ 07701 in Monmouth County. The practice phone is (732) 235-3939.

Dr. Desai's primary practice is Rutgers Cancer Institute of New Jersey in Tinton Falls, New Jersey. Dr. Desai is also affiliated with Robert Wood Johnson University Hospital. The medical group on file is Rutgers-RWJ Scleroderma Program. Dmand AI also links Dr. Desai to 3 more hospitals, 5 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Desai practices, 7 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Desai's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Desai is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Desai's licenses on file in 8 states: New Jersey, California, Maryland, Pennsylvania, Arizona, Missouri, Nevada and Tennessee.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, breast cancer radiation, cervical cancer radiation, lung cancer radiation, pancreatic cancer radiation and prostate cancer radiation among the conditions Dr. Desai treats.

CMS data shows 749 Medicare services from Dr. Desai across 10 procedure codes in 2024, for 177 Medicare patients. Medicare paid $49,381 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 177 Medicare patients who saw Dr. Desai in 2024. The largest group is 65 to 74, with 88 patients. 75% of them have cancer, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Desai's median patient age at 67, with 50% women.

In 2024, Dr. Desai wrote 53 Medicare Part D claims for 32 patients. 92% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $168 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

Dr. Desai accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Desai. Dr. Desai's most frequent co-author is James W. Fleshman, MD.

Dmand AI links Dr. Desai to 2 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Tongue Neoplasms and Prostatic Diseases. Radiation Therapy Oncology Group sponsors the most, 2.

CMS Open Payments shows 17 general payments to Dr. Desai from 15 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 97% of the total. Covidien LP paid the most, $188.

Dmand AI lists 1 award for Dr. Desai.

Dr. Desai graduated from Kurnool Medical College in 1979. Dr. Desai is a member of ASCO.

Dr. Desai is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Horizon Blue Cross Blue Shield of New Jersey. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.